MedTrace Logo

Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study

NCT01669954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2012-08-21

No results posted yet for this study

Summary

The purpose of this study is to determine the bone mineral density in male and female patients with HIV infection according to age groups.

This will enable a practical approach to screening for osteoporosis and the management and prevention of fragility fractures in people with HIV.

In addition, all risk factors commonly associated with fragility fractures and osteoporosis are collected, as is HIV drug history.

Hence, as secondary outcomes, the associations with reduced bone mineral density can be ascertained.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Barry S Peters, MD PhD · King's College London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-05-31
Completion
2012-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01669954 on ClinicalTrials.gov